Empire Eye and Laser Center actively participates in several US Food and Drug Administration Phase III and Phase IV trials and studies. We have a special, standardized, and calibrated exam lane for our research evaluations. Directed by Dr. Daniel Chang, our participation premarket approval investigations means that our patients uniquely have access to technologies that may be years away for patients in the United States. The goal of all of these studies is safer and better outcomes for our patients.

Current projects include work in the following areas:

  • Visual outcomes, functional outcomes, and patient satisfaction in patients with multifocal IOLs
  • Improving IOL refractive outcomes with multiple repeated biometry measurements
  • Intraoperative and postoperative alignment and centration of IOLs
  • Investigating next generation multifocal IOL technology

Being a patient at Empire Eye and Laser Center means that you have access to the very best medical and surgical eye care that is currently available.

If you are interested in participating in clinical research, please call our office at 661-325-3937 and ask for Jacque, our Research Coordinator.